Murine hepatitis virus--a model for virus-induced CNS demyelination

A E Matthews1, S R Weiss, Y Paterson

  • 1Department of Microbiology, University of Pennsylvania School of Medicine, Philadelphia 19104-6076, USA.

Insights

Murine hepatitis virus (MHV) can infect the central nervous system (CNS), causing demyelination similar to multiple sclerosis (MS). This review examines the immune response to MHV in the CNS and liver, focusing on recent findings.

Area of Science:

  • Neurovirology
  • Immunology
  • Demyelinating Diseases

Background:

  • Murine hepatitis virus (MHV) primarily infects the liver, but some strains target the central nervous system (CNS).
  • CNS infection by MHV leads to encephalitis and demyelination, mirroring aspects of human diseases like multiple sclerosis (MS).
  • MHV models are crucial for understanding immune responses in viral CNS infections, demyelination, and remyelination.

Purpose of the Study:

  • To review the current understanding of MHV-induced demyelination in the CNS.
  • To explore the role of the immune system in MHV pathogenesis within the CNS and liver.
  • To focus on recent research (last 5 years) regarding the immune response to MHV.

Main Methods:

  • Literature review of studies published within the last 5 years.
  • Analysis of research on MHV tropism for the CNS and liver.
  • Examination of immune responses in MHV-induced demyelination and viral clearance.

Main Results:

  • MHV strains exhibit varying tropism, with some specifically targeting the CNS.
  • CNS demyelination induced by MHV shares pathological features with human demyelinating diseases.
  • The precise mechanisms of MHV-induced demyelination and the immune system's role remain incompletely understood.

Conclusions:

  • MHV serves as a valuable model for studying CNS demyelinating diseases and immune system interactions.
  • Further research is needed to elucidate the exact mechanisms of MHV-induced demyelination.
  • Understanding the immune response to MHV is critical for developing therapeutic strategies for CNS demyelinating disorders.